Company profile: Harbor MedTech
1.1 - Company Overview
Company description
- Provider of tissue regeneration products for chronic wounds, hernia and joint repair. Offers Architect, a stabilized collagen matrix for various chronic skin wounds; BPMatrix, a collagen patch for orthopedic soft tissue injuries such as tendon repairs; and BriDGE Technology, a patented method to create a stabilized collagen matrix that supports tissue regeneration, accelerates wound healing, and prevents infection.
Products and services
- BriDGE Technology: A patented method creating a stabilized collagen matrix from intact tissue that supports tissue regeneration, accelerates wound healing, and prevents infection by recruiting the patient's own growth factors
- Architect: A stabilized collagen matrix treating chronic skin wounds, including diabetic ulcers, pressure sores, venous and chronic vascular ulcers, draining wounds, second-degree burns, trauma wounds, and surgical wounds
- BPMatrix: A collagen patch derived from BriDGE processing technology that supports tissue regeneration in orthopedic soft-tissue injuries, including tendon repairs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Harbor MedTech
Lamellar
HQ: United Kingdom
Website
- Description: Provider of novel healthcare products based on mimicry or modification of the lamellar body secretory system, leveraging Lamellasomes™ technology and associated intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lamellar company profile →
Neuroplast
HQ: The Netherlands
Website
- Description: Provider of neuro-regenerative personalized medicine, a promising therapy that needs dedicated uniform standards and regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuroplast company profile →
MiMedx
HQ: United States
Website
- Description: Provider of wound care and therapeutic biologics, offering human amniotic membrane and umbilical cord allografts for wound care (including diabetic foot ulcers and venous leg ulcers) and surgical applications. Products include EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, AMNIOBURN for burn care, and AXIOFILL, a biocompatible acellular human placental extracellular matrix to replace or supplement damaged or inadequate integumental tissue.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MiMedx company profile →
ProFibrix
HQ: The Netherlands
Website
- Description: Provider of hemostasis and regenerative medicine products, including Fibrocaps, a dry powder topical hemostat and tissue sealant based on fibrinogen and thrombin that stops acute and severe bleeding during surgery or trauma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProFibrix company profile →
Stability Biologics
HQ: United States
Website
- Description: Provider of human tissue and bone graft products, delivering allograft solutions to physicians, hospitals, and surgery centers throughout the United States, including Physio (100% human bone for mineralization and new bone regeneration), AmnioCore and AmnioCore Burn (amniotic membrane/tissue barriers), and DBM Putty and DBM Crush-Mix for filling bone voids and gaps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stability Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Harbor MedTech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Harbor MedTech
2.2 - Growth funds investing in similar companies to Harbor MedTech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Harbor MedTech
4.2 - Public trading comparable groups for Harbor MedTech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →